Dr. Reddy's Laboratories, Incorporated

Schering Corporation

Vilas Hareshwar Dahanukar

Krishna Mohan Thalabathula

Ilia A Zavialov

Hoa N Nguyen

Vikas Sadashiv Gajare

Sandip Ramdas Khobare

Satishbhai Sukhlalbhai More

Anantha R Sudhakar

Wenxue Wu

William W Leong

Minzhang Chen

Michael Siegfried Quirmbach

Jeonghan Park

George S Wong

Michael D Green

Hong-Chang Lee

Loc Thanh Tran

Juergen Weber

Ingyu Jeon

Goverdhan Gilla

Cecilia A Orr

Bosco D'Sa

Feng Liang

Rakeshwar Bandichhor

Raghupathi Reddy Anumula

Tetsuo Iwama

Veerender Murki

Man Zhu

Xiongwei Shi

Rama Mohan Hindupur

Yakambram Bojja

Debjit Basu

Venkata Annapurna Sasikala Cheemalapati

Kumar Sarvesh

Srikanth Sarat Chandra Gorantla

Syam Kumar Unniaran Kunhimon

Rajender Datrika

Sampath Aalla

Sreenivasulu Madi Shetty

Ravi Ram Chandra Sekhar Elati

Upadhya Timmana

Abir Kumar Pal

Mahendar Macha

Venkata Madhubabu Meesala

Uday Kumar Neelam

Anna Fryszkowska

Shankar Ramanathan

Shirshendu Das Gupta

Amit Kumar Mandal

Sergio Ferrino

Sanjay Reddy Alieti

Diego Torres

Srinivas Reddy Poreddy

Naresh Kumar Reddy Dinne

Cecelia Proietti

Shannon Zhao

Upadhya Timmanna

Yi Liu

Sreenivasulu Kurella

Rashid Abdul Rehman Khan

Sudhir Sai

Shweta Mahajan Kulkarni

Cecilia Proietti

Xiongwei Shih

The present application relates to amine salt of obeticholic acid. Specifically, the present application relates to (S)-&#x3b1;-methylbenzylamine and diethylamine salt of obeticholic acid. The present application also relates to a process for preparation of amorphous form of obeticholic acid comprising converting amine salt of obeticholic acid to amorphous form of obeticholic acid.

Amine salt of obeticholic acid

The present application relate to a process for preparation of 4-Methylene tetrahydrofuran compound of formula II, which is useful as an intermediate for the preparation of halichondrin B analogues such as Eribulin.

Process for preparation of eribulin and intermediates thereof

The invention of the present application relates to the process for the preparation of intermediates of obeticholic acid and their conversion to obeticholic acid. The process involves the conversion of compound of formula (VI) to compound of formula (VII) in presence of an organic base.

Process for preparation of obeticholic acid

The present application relates to a regioselective and stereoselective processes for the preparation of dehydroepi-androsterone (DHEA) and processes for its intermediates.

Processes for the preparation of dehydroepiandrosterone and its intermediates

Provided are processes for preparing Ticagrelor and its intermediates that are useful in the processes. Also provided are salts of Ticagrelor, their processes and solid dispersion of Ticagrelor having Ticagrelor in amorphous form.

Preparation of ticagrelor

The present application relates to an improved process for the preparation of (S)-equol (1). The present application also relates to novel intermediates of formula (7), (7A), (8) and (9) and their use for the synthesis of (S)-equol. 

Process for producing (S)-equol

There is provided a process for preparing 21-acetyloxy-6-alpha-fluoro-pregna-1,4,9(11),16-tetraene-3,20-dione compound of Formula I, which comprises reacting 21-acetyloxy-pregna-1,3,5,9(11),16-pentaene-3-oxo acetate with a fluorinating agent.

Process for the preparation of fluorotetraene

The present invention is directed to the synthesis of 4-[4-[(R)-[1-[cyclopropylsulfonyl)-4-piperidinyl](3-fluorophenyl)methyl]-3(S)-methyl-1-piperazinyl]-1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]-4-methylpiperidine], and intermediates therefor from readily available starting materials by a novel route.

Synthesis of CCR5 receptor antagonists

In one embodiment, the present application relates to a process of making a compound of formula I: and to certain intermediate compounds that are made within the process of making the compound of formula I.

Process and intermediates for the preparation of (1R,2S,5S)-3-azabicyclo[3,1,0]hexane-2-carboxamide, N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[(2S)-2-[[[1,1-dimethylethyl]amino]carbonylamino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl

Growing community of inventors

Hyderabad Telangana, India

Vilas Hareshwar Dahanukar